Better Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q2 2024 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q3 2024 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q4 2024 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q1 2025 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q2 2025 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q3 2025 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q4 2025 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q1 2026 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q2 2026 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q3 2026 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q4 2026 | 1 | -$0.15 | -$0.15 | -$0.15 |
Better Therapeutics, Inc. Earnings Date And Information
Better Therapeutics, Inc. last posted its earnings results on Thursday, November 9th, 2023. The company reported $-0.15 earnings per share for the quarter, topping analysts' consensus estimates of $-0.19 by $0.04. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Better Therapeutics, Inc. has generated $-2 earnings per share over the last year ($-1.69 diluted earnings per share) and currently has a price-to-earnings ratio of -0. Better Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based on prior year's report dates.
Better Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/09/2023 | Q3 2023 | -$0.19 | -$0.15 | 0.04 | $0 | $0 |
| 08/09/2023 | Q2 2023 | -$0.39 | -$0.24 | 0.15 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.74 | -$0.39 | 0.35 | $0 | |
| 03/30/2023 | Q4 2022 | -$0.53 | -$0.37 | 0.16 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.50 | -$0.48 | 0.02 | $0 | |
| 08/11/2022 | Q2 2022 | -$0.47 | -$0.42 | 0.05 | $0 | |
| 05/13/2022 | Q1 2022 | -$0.30 | -$0.43 | -0.13 | $0 | |
| 03/28/2022 | Q4 2021 | -$0.46 | -$0.71 | -0.25 | $284,000 | |
| 11/22/2021 | Q3 2021 | -$1.66 | -$0.01 | 1.65 | $0 | |
| 08/19/2021 | Q2 2021 | -$0.37 | $0 | |||
| 05/24/2021 | Q1 2021 | -$0.23 | $0 | |||
| 03/30/2021 | Q4 2020 | -$0.09 | $1,038 | |||
| 09/29/2020 | Q3 2020 | -$0.50 | $1 | |||
| 06/29/2020 | Q2 2020 | -$0.04 | $3,000 | |||
| 03/30/2020 | Q1 2020 | -$0.36 | $4 |
Better Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Better Therapeutics, Inc.'s earnings date?
Better Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates.
-
Did Better Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Better Therapeutics, Inc. (:BTTX) reported $-0.15 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.19 by $0.04.
-
How can I listen to Better Therapeutics, Inc.'s earnings conference call?
The conference call for Better Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Better Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Better Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Better Therapeutics, Inc. generate each year?
Better Therapeutics, Inc. (:BTTX) has a recorded net income of $0. Better Therapeutics, Inc. has generated $-1.69 earnings per share over the last four quarters.
-
What is Better Therapeutics, Inc.'s price-to-earnings ratio?
Better Therapeutics, Inc. (:BTTX) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is -0.
